Ambu's endoscope business would have worked out without Invendo acquisition, CEO says
The main product the Danish medtech company gained through the purchase was a single-use endoscope, SC210, which never made it to market.
by mikkel aabenhus hemmingsen, translated by daniel pedersen
Ambu could have made its single-use endoscope business area work even without the DKK 1.7bn (USD 222m) acquisition of German Invendo, according to the medtech company’s CEO, Britt Meelby Jensen, speaking in an interview with Danish business daily Børsen.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Former Ambu employee fined for "negligent insider trading"
For subscribers
Clock is ticking on post-Brexit UK medical equipment laws
For subscribers
